Antiphospholipid Antibodies as Potential Prognostic Indicators of Recurrent Myocardial Infarction.

BACKGROUND: Inflammation and autoimmunity are pivotal contributors to myocardial infarction (MI) risk, with emerging evidence linking autoimmune disorders to MI pathogenesis. To further elucidate this relationship, we conducted a prospective cohort s…

Preview only. Read the full abstract at the source